Maze Therapeutics (MAZE) EBT (2024 - 2026)
Maze Therapeutics (MAZE) reported EBT of -$19.6 million for Q1 2026, up 40.23% on a YoY basis from -$14.0 million in Q1 2025, and up 43.31% sequentially from -$34.6 million in Q4 2025.
Maze Therapeutics (MAZE) EBT (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of EBT data on file, last reported at -$19.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 40.23% year-over-year to -$19.6 million; the trailing twelve-month figure through Mar 2026 stood at -$117.9 million (down 322.04% YoY), and the FY2025 full-year result was -$131.1 million, down 345.53% from the prior year.
- EBT improved to -$19.6 million in Q1 2026, from -$34.6 million in the prior quarter.
- In the past five years, EBT ranged from a high of $140.8 million in Q2 2024 to a low of -$34.6 million in Q4 2025.
- A 3-year average of -$10.3 million and a median of -$29.9 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT sank 123.92% in 2025 and soared 40.23% in 2026, its largest moves.
- Tracing MAZE's EBT over 3 years: stood at -$29.9 million in 2024, then fell by 15.79% to -$34.6 million in 2025, then jumped by 43.31% to -$19.6 million in 2026.
- Business Quant data shows MAZE's EBT at -$19.6 million in Q1 2026, -$34.6 million in Q4 2025, and -$30.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | -19.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.60 Mn |
| Dec 31, 2025 | -34.57 Mn |
| Sep 30, 2025 | -30.09 Mn |
| Jun 30, 2025 | -33.68 Mn |
| Mar 31, 2025 | -32.79 Mn |
| Dec 31, 2024 | -29.85 Mn |
| Sep 30, 2024 | -25.03 Mn |
| Jun 30, 2024 | 140.78 Mn |
| Mar 31, 2024 | -27.73 Mn |